𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dexamethasone in advanced breast cancer

✍ Scribed by Basil A. Stoll

Publisher
John Wiley and Sons
Year
1960
Tongue
English
Weight
625 KB
Volume
13
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Concurrent radiochemotherapy in advanced
Concurrent radiochemotherapy in advanced breast cancer
✍ Allen G. Meek; Stanley E. Order; Martin D. Abeloff; David Ettinger; R. Robinson πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 454 KB πŸ‘ 2 views
Neoadjuvant chemotherapy in locally adva
Neoadjuvant chemotherapy in locally advanced breast cancer
✍ Singh, Gurpreet; Singh, Deepinder P.; Gupta, Devender; Muralikrishna, Bhavaraju πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 403 KB πŸ‘ 2 views

Thirty-eight patients with locally advanced breast cancer (Stage HI) were treated over a 3-year period. All patients initially received two cycles of CMF (cyclophosphamide, 100 mg/m2 p.0. dl-14; methotrexate 40mg/m2 intravenously (iv), d l and d8., 5 Fluorouracil 500 mg/m2 iv d l and d8). They were

Diethylstilbestrol revisited in advanced
Diethylstilbestrol revisited in advanced breast cancer management
✍ Boyer, Michael J. ;Tattersall, Martin H. N. πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 361 KB

## Abstract Prior to the introduction of tamoxifen, diethylstilbestrol (DES) was widely used as the first‐line endocrine therapy in postmenopausal women with advanced breast cancer. Since randomized trials reported that tamoxifen has a similar response rate but fewer side effects than DES, its use